학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 364건 | 목록 1~20
Academic Journal
Puig N; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Centro de Investigación del Cancer, Salamanca, Spain.; Diels J; The Janssen Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium.; van Sanden S; The Janssen Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium.; Mendes J; The Janssen Pharmaceutical Companies of Johnson & Johnson, Lisbon, Portugal. jmendes6@ITS.JNJ.com.; J&J Innovative Medicine, 1000 US Highway 202, Raritan, NJ, 08869, USA. jmendes6@ITS.JNJ.com.; Burnett H; Evidera Inc., Wilmington, NC, USA.; Cichewicz A; Evidera Inc., Wilmington, NC, USA.; Lee S; The Janssen Pharmaceutical Companies of Johnson & Johnson, Lisbon, Portugal.; Hernando T; The Janssen Pharmaceutical Companies of Johnson & Johnson, Madrid, Spain.; Schecter JM; The Janssen Pharmaceutical Companies of Johnson & Johnson, Raritan, NJ, USA.; Lendvai N; The Janssen Pharmaceutical Companies of Johnson & Johnson, Raritan, NJ, USA.; Patel N; Legend Biotech USA Inc., Somerset, NJ, USA.; Sanchez-Pina JM; Hospital Universitario 12 de Octubre, Madrid, Spain.; Rocchi S; Azienda Opedaliero-Universitaria Policlinico Sant'orsola Malpighi di Bologna, Bologna, Italy.; Mina R; Division of Hematology, AOU Città della Salute e della Scienza di Torino, and Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy.; Corradini P; Fondazione IRCCS Istituto Nazionakle dei Tumori Milano, University of Milano, Milan, Italy.; Cavo M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Seràgnoli Institute of Hematology, Bologna, Italy.; Miguel JS; Cancer Center Clinica Universidad Navarra, CIMA, IDISNA, Pamplona, Spain.; Shune L; The University of Kansas Medical Center, Kansas City, KS, USA.; Khan AM; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Sidana S; Stanford University School of Medicine, Stanford, CA, USA.; Leleu X; CHU Poitiers, Poitiers, France.; Manier S; University of Lille, CHU Lille, Lille, France.; Lipe B; University of Rochester Medical Center, Rochester, NY, USA.; Weisel K; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Martinez-Lopez J; Hematological Malignancies Clinical Research Unit, Hospital 12 de Octubre, Universidad Complutense, Centro Nacional de Investigaciones Oncológicas, CIBERONC, Madrid, Spain.
Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Conference
Clinical Lymphoma Myeloma & Leukemia
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
Academic Journal
Corona M; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain.; García-Vicente R; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain.; Saez-Marin AJ; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Ancos-Pintado R; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain.; Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid, Madrid, Spain.; Rodríguez-Garcia A; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain.; Arroyo A; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain.; Blanco A; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Chari A; Hematology Department, University of California San Francisco, San Francisco, California, USA.; Martin T; Hematology Department, University of California San Francisco, San Francisco, California, USA.; Wolf J; Hematology Department, University of California San Francisco, San Francisco, California, USA.; Rey-Bua B; Hematology Department, Hospital Clinico Universitario de Salamanca, Salamanca, Spain.; Mateos MV; Hematology Department, Hospital Clinico Universitario de Salamanca, Salamanca, Spain.; Kortüm KM; Hematology Department, University Hospital Würzburg, Würzburg, Germany.; Riedhammer C; Hematology Department, University Hospital Würzburg, Würzburg, Germany.; Tamariz-Amador LE; Hematology Department, Clínica Universidad de Navarra, Pamplona, Spain.; Valencia E; Hematology Department, Clínica Universidad de Navarra, Pamplona, Spain.; Rodríguez-Otero P; Hematology Department, Clínica Universidad de Navarra, Pamplona, Spain.; San Miguel J; Hematology Department, Clínica Universidad de Navarra, Pamplona, Spain.; Ibarra G; Hematology Department, Hospital Germans Trias i Pujol, Badalona, Spain.; Oriol A; Hematology Department, Hospital Germans Trias i Pujol, Badalona, Spain.; Cedena MT; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; López-Muñoz N; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Alonso R; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Calbacho M; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Sanchez-Pina JM; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; Linares M; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain jmarti01@med.ucm.es mlinares@ucm.es.; Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid, Madrid, Spain.; Martínez-López J; Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain jmarti01@med.ucm.es mlinares@ucm.es.; Department of Translational Hematology, Instituto de Investigación Hospital 12 de Octubre (imas12), Hematological Malignancies Clinical Research Unit H12O-CNIO, Madrid, Spain.; Department of Medicine, Medicine School, Universidad Complutense de Madrid, Madrid, Spain.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Sáez-Marín AJ; Department of Hematology, University Hospital 12 de Octubre, Madrid, Spain.; Hernandez-Ibarbu G; TriNetX Europe, Biomedical Informatics Group, NV, Sint-Martens-Latem, Belgium.; Alba LM; Department of Hematology, University Hospital 12 de Octubre, Madrid, Spain.; Babio RM; Department of Hematology, University Hospital 12 de Octubre, Madrid, Spain.; Tamayo A; Department of Hematology, University Hospital 12 de Octubre, Madrid, Spain.; Fonseca AC; Department of Hematology, University Hospital 12 de Octubre, Madrid, Spain.; Sanchez-Pina JM; Department of Hematology, University Hospital 12 de Octubre, Madrid, Spain.; Alonso-Fernández RA; Department of Hematology, University Hospital 12 de Octubre, Madrid, Spain.; Lopez-Muñoz N; Department of Hematology, University Hospital 12 de Octubre, Madrid, Spain.; Blanco A; Department of Hematology, University Hospital 12 de Octubre, Madrid, Spain.; Justo P; Department of Hematology, University Hospital 12 de Octubre, Madrid, Spain.; Garcia-Barrio N; Department of Data Science, Hospital 12 de Octubre, Research Institute Hospital 12 de Octubre Madrid, Spain.; Tato A; Department of Data Science, Hospital 12 de Octubre, Research Institute Hospital 12 de Octubre Madrid, Spain.; Cruz JL; Department of Hematology, University Hospital 12 de Octubre, Madrid, Spain.; Perez-Rey D; Department of Inteligencia Artificial, ETSI Informaticos, Universidad Politecnica de Madrid, Boadilla del Monte, Madrid, Spain.; Jimenez-Ubieto A; Department of Hematology, University Hospital 12 de Octubre, Madrid, Spain; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain; Medicine School, Universidad Complutense de Madrid, Madrid, Spain.; Cruz J; Imas12 Research Institute, Hospital Universitario 12 de Octubre, Madrid, Spain.; Calbacho M; Department of Hematology, University Hospital 12 de Octubre, Madrid, Spain; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain.; Martínez-López J; Department of Hematology, University Hospital 12 de Octubre, Madrid, Spain; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain; Medicine School, Universidad Complutense de Madrid, Madrid, Spain. Electronic address: jmarti01@ucm.es.
Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE
Academic Journal
García-Vicente R; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain.; Rodríguez-García A; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain.; Ancos-Pintado R; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain.; Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid, Madrid, Spain.; Arroyo A; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain.; Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid, Madrid, Spain.; Ortega-Hernández A; Microbiota and Vascular Biology Laboratory, Hospital Clínico San Carlos-Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.; Bragado-García I; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain.; Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid, Madrid, Spain.; Castellano E; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain.; Ortiz-Ruiz A; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain.; Navarro-Aguadero MÁ; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain.; Modrego J; Microbiota and Vascular Biology Laboratory, Hospital Clínico San Carlos-Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.; ImFINE Research Group, Department of Health and Human Performance, Faculty of Physical Activity and Sport Science-INEF, Universidad Politécnica de Madrid, Madrid, Spain.; Leivas A; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain.; García-Villalba R; Laboratory of Quality, Safety, and Bioactivity of Plant Foods, CEBAS-CSIC, Murcia, Spain.; Tomás-Barberán FA; Laboratory of Quality, Safety, and Bioactivity of Plant Foods, CEBAS-CSIC, Murcia, Spain.; Sánchez-Pina JM; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain.; Alonso R; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain.; Cedena MT; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain.; Hernández-Sánchez M; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain.; Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid, Madrid, Spain.; Carpio C; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology, Universitat Autónoma de Barcelona, Barcelona, Spain.; Barba P; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology, Universitat Autónoma de Barcelona, Barcelona, Spain.; Carbonell D; Department of Hematology, Gregorio Marañón University Hospital, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Kwon M; Department of Hematology, Gregorio Marañón University Hospital, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Bastos-Oreiro M; Department of Hematology, Gregorio Marañón University Hospital, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.; Martín García-Sancho A; Deparment of Hematology, University Hospital of Salamanca, IBSAL, CIBERONC, University of Salamanca, Salamanca, Spain.; Jiménez-Ubieto A; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain.; Valeri A; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain.; Gómez-Garre D; Microbiota and Vascular Biology Laboratory, Hospital Clínico San Carlos-Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.; Department of Physiology, Medicine School, Universidad Complutense de Madrid, Madrid, Spain.; Martínez-López J; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain.; Department of Medicine, Medicine School, Universidad Complutense de Madrid, Madrid, Spain.; Linares M; Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain.; Department of Biochemistry and Molecular Biology, Pharmacy School, Universidad Complutense de Madrid, Madrid, Spain.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Aten Primaria
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Recercat. Dipósit de la Recerca de Catalunya
Universidad de Zaragoza
Zaguán: Repositorio Digital de la Universidad de Zaragoza
Atención Primaria, Vol 52, Iss 10, Pp 705-711 (2020)
검색 결과 제한하기
제한된 항목
[검색어] Sanchez‐Pina, J.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어